A novel murine plasma membrane protein has been identified in subpopulations of macrophages. It has an intracellular N-terminal domain, a transmembrane domain, and an extracellular region with a short spacer, an 89 Gly-Xaa-Yaa repeat-containing collagenous domain, and a C-terminal cysteine-rich domain. In situ hybridization and immunohistochemical staining have localized the protein to a subset of macrophages in the marginal zone of the spleen and the medullary cord of lymph nodes. No expression was observed in macrophages of liver or lung. Transfected COS cells synthesized a native trimeric plasma membrane protein that bound labeled bacteria and acetylated LDL, but not yeast or Ficoll. The results suggest that the novel protein is a macrophage-specific membrane receptor with a role in host defense, as it shows postnatal expression in macrophages, which are considered responsible for the binding of bacterial antigens and phagocytosis.
Introduction
Macrophages form an important part of the host defense system in normal and pathological processes. These cells are derived from a pool of monocytes that have migrated from blood into peripheral tissues such as those of the liver, spleen, lung, lymph nodes, peritoneum, skin, brain, and bone, where they differentiate into macrophages (Van Furth, 1982) .
The major characteristic of macrophages is their ability to recognize, internalize, and destroy a variety of foreign and endogenous substances and pathogens, such as bacteria, parasites, and viruses. The exact recognition mechanism for nonself pathogens is unknown, but it has been proposed that receptors with broad binding specificity are used to discriminate between self and nonself (Gordon et al., 1988; Krieger and Hertz, 1994) . Macrophages are also thought to play a role in the immune response by presenting foreign antigens to lymphocytes (Unanue and Allen, 1987) .
Macrophage scavenger receptors with broad ligand specificity have been suggested to play a role in the binding of foreign antigens, in addition to their apparently important role in atherogenesis (for review, see Krieger and Hertz, 1994) . Scavenger receptors types I and II are trimeric membrane proteins with a small N-terminal intracellular domain, a transmembrane domain, and an extracellular region containing a short spacer domain, an a-helical coiled-coil domain, and a triple-helical collagenous domain Rohrer et al., 1990) . The type I receptor contains an additional C-terminal cysteine-rich domain, These receptors, which are present in macrophages in diverse tissues, including liver and lung, have been shown to bind a variety of ligands, such as chemically modified lipoproteins and albumin, polyribonucleotides, polysaccharides, phospholipids, and asbestos (Krieger and Hertz, 1994) . Furthermore, the scavenger receptors are thought to play a key role in atherogenesis by mediating uptake of modified low density lipoprotein (LDL) in arterial walls, and in host defense by binding bacterial endotoxins, bacteria, and protozoa (Krieger and Hertz, 1994) . Several collagenous proteins without structural functions belong to the host defense system, such as complement factor Clq, conglutinin, mannose-binding proteins, and pulmonary surfactant-associated proteins.
In the present study, we have cloned and characterized a novel macrophage receptor with a coilagenous structure (referred to as MARCO) that is expressed postnatally in a subset of macrophages in mouse spleen and lymph nodes, but not in the liver or lung. This receptor was shown to bind to bacteria and acetylated LDL, but not to yeast.
Results

cDNA Clones and Predicted Primary Structure
Screening of a mouse macrophage cDNA library with a human type Xlll collagen cDNA probe yielded several clones spanning 1.8 kb encoding a protein that has not, to our knowledge, been described previously. This sequence contained an apparent 159 bp 5'-end untranslated region and a 1554 bp open reading frame, followed by a />156 bp 3'-end untranslated region containing a TGA translation stop codon, a putative AATAAA polyadenylation signal, and a poly(A) tail. The sequence surrounding the putative initiator methionine codon ATG does not agree completely with the Kozak consensus sequence, but it can be designated as a strong translation initiation site when positions -3 and +4 are being considered (Kozak, 1989 Figure 1 . Nucleotide-Derived Amino Acid Sequence of the Murine MARCO Subunit Chain The cDNA-deduced amino acid sequence is shown with the singleletter code. The tentative transmembrane domain II is indicated by an underline, and cysteine residues and the two potential glycosylation sites are circled. The collagenous domain iV is boxed.
The cDNA-d erived 518 amino acid sequence was shown to be unique ( Figure 1 ) for a polypeptide of 52,738 Da. The open reading frame starts with a hydrophilic domain I (residues 1-49) containing one cysteine, and thus, the protein does not contain a hydrophobic signal peptide. The hydrophobic domain II (residues 50-74) is followed by a hydrophilic domain III (residues 75-149) containing two cysteine residues and two putative N-glycosylation sites (Figure 1 ). Domain IV (residues 150-419) has a typical collagenous sequence characterized by 89 Gly-XaaYaa triplets interrupted at one location (residues 174-176) by Ala-Glu-Lys. The C-terminal domain V (residues 420-518) has six cysteines. This domain showed 48.9% sequence identity with the C-terminal domain of scavenger receptor type I. The sequences of domains I, II, and III showed no significant homology with the scavenger receptor or other known proteins. The novel macrophage receptor with collagenous structure described here is referred to as MARCO.
Expression of MARCO
By Northern blot analyses, MARCO was shown to be strongly expressed in spleen and peritoneal macrophages of adult mice, but not in other tissues, and also in a cultured macrophage cell line IC-21 (ATCC TIB 186) (data not shown).
By use of in situ hybridization, no signals above background were observed in 14-to 17-day-old embryonic tissues (data not shown), but strong signals were seen with the MARCO antisense probe in a highly region-specific manner, in both spleen and lymph nodes of 2-month-old mice (Figures 2A, 2B, 2G, and 2H) . In contrast, all other tissues examined, including lung and liver, which are rich in macrophages, did not show signals above background (data not shown). In the spleen, the signals were present in macrophage-like cells in the marginal zone at the interface of the white and red pulps (Figures 2A and 2B ). In (B) For studies in vivo, rabbit antiserum to the extracellutar domain V of MARCO was injected intravenously into a mouse, after which tissue was removed and processed for staining using an FITC-labeled antirabbit IgG. The label was confined to marginal zone (mz) macrophages located between the red (r) and white (w) pulps. Antibodies against domain I did not bind cells (data not shown). Scale bars in (A), 100 nm; in (B), 10 pro.
Immunohistochemical Localization of MARCO to Macrophages
The MARCO protein was immunolocalized by using antibodies raised against the putative extracellular and intracellular domains I and V, respectively. Analysis of 2-month-old mouse spleen tissues revealed specific staining in macrophages located in the marginal zone with both antibodies ( Figure 2C ). No specific staining was observed in liver, which is rich in scavenge~" receptor-containing macrophages. The immunohistochemical analysis showed codistribution of MARCO and the marginal zone macrophage marker ER-TR9 (Dijkstra et al., 1985) in macrophages of spleen ( Figures 2C, 2D , and 2E) and in lymph nodes (data not shown). Neither MARCO nor ER-TR9 antigens were present in macrophages lining the marginal sinus, which normally express the sialoadhesin receptor recognized by the MOMA-1 antibody( Figure 2F ; Kraal and Janse, 1986; Kraal, 1992) .
Immunolocalization and Orientation of MARCO on the Macrophage Cell Surface
Cultured IC-21-transformed macrophages were processed for field emission scanning electron microscopy of the cell surface and reacted with antisera against domains I and V followed by incubation with a gold-labeled second antibody. The antibody against the C-terminal domain V readily bound to the cell surface ( Figure 3A ), while the antibody against the N-terminal domain I did not (data not shown). The antibodies evenly decorated the cell surface and protruding pseudopodia.
The orientation of MARCO in the plasma membrane was further investigated by injecting antisera against domains I or V intravenously into mouse, after which the tissues were analyzed for staining by using a fluorescein isothiocyanate (FITC)-conjugated second antibody. All tissues studied were negative, except for the spleen, which exhibited staining of marginal zone macrophages with antiserum against domain V ( Figure 3B ). However, no staining was observed with domain I antibodies (data not shown). Together, these results demonstrated that domains I and V are intracellular and extracellular, respectively.
MARCO Is a Disulfide-Linked Trimer
The presence of several cysteine residues and a 270-residue Gly-Xaa-Yaa repeat-containing sequence indicated that MARCO is a disulfide-linked trimer with a collagen triple helix. To analyze this, protein was extracted from mouse spleen or kidney tissues, immunoprecipitated, and separated by SDS-polyacrylamide gel electrophoresis (PAGE) followed by immunoblotting. When protein from spleen was analyzed on SDS-PAGE without reduction, a major band of -210,000 Da and a second slightly smaller band were seen with both antibodies ( Figure 4A , lanes 1 and 2). A 160,000 Da band representing immunoglobulin G (IgG) was also detected. After reduction, one diffuse major band of -80,000 Da and one weaker, slightly smaller band were observed ( Figure 4A , lane 5), in addition to a strong 50,000 Da IgG band. No specific protein was immunoprecipitated from the kidney extract with the MARCO antibodies (see Figure 4A , lanes 3, 4, and 6). These results demonstrated that MARCO is a disulfidelinked trimer. The smaller bands recognized by both antibodies might represent forms with different posttranslational modifications.
Metabolic Labeling of Transfected COS Cells
COS cells, which do not express MARCO, were transfected with the cDNA in the presence or absence of tunicamycin to study glycosylation of the protein, and also to determine whether native MARCO trimers can be formed with a single chain type. Incubation with tunicamycin, which inhibits N-glycosylation, revealed a MARCO chain of -50,000 Da, which agrees well with the calculated size ( Figure 4B , lane 5). When the cells were pulse labeled for 1 or 4 hr, the major band had a size of about 60,000 Da. Additionally immunoprecipitated bands of sizes up to 80,000 Da were observed after reduction ( Figure 4B , lane 3). Following an 18 hr chase, the 60,000 Da bands had disappeared, but two bands of 70,000 Da and a doublet of about 80,000 Da remained ( Figure 4B, lane 4) . These results suggest that the microheterogeneity of the subunit MARCO chains is due to differences in glycosylation, but not proteolysis, as these proteins were detected with antibodies reacting with both ends of the polypeptide (data not shown). Freeman et al. [1990] .) The domains are indicated by Roman numbers, and the amino acid (aa) residue sizes of the subunit chains are indicated below.
coil, a neutral polysaccharide normally taken up by marginal zone macrophages, while the IC-21 macrophage cells readily bound this compound (data not shown). We further showed that MARCO-expressing COS cells bound 1,1'-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine perchlorate(Dil)-acetylated LDL (data not shown).
Discussion
The present study provides a description of MARCO, a macrophage receptor with collagenous structure expressed in specific macrophages in spleen and lymph nodes. This receptor was shown to bind both gram-positive and gram-negative bacteria and acetylated LDL, but not yeast. The structure of MARCO shows some resemblance to scavenger receptor type I ), but it is clearly a distinct gene product with different binding properties.
MARCO Is a Membrane-Bound Trimer
The cDNA-derived amino acid sequence and protein studies carried out showed that MARCO is a disulfide-bonded trimer with a partial collagenous structure. The tunicamycin labeling studies demonstrated that the 210,000 Da protein observed by SDS-PAGE was due to glycosylation of the three -52,000 Da subunits. The Ala-Glu-Lys interruption in the collagenous sequence of the polypeptide chain indicates that the triple helix of MARCO has a kink or hinge similar to that present in collagens with interrupted triple helices. At present, it is not known whether the MARCO molecules in vivo are homo-or heterotrimers, but our experiments demonstrated that homotrimers can be formed in transfected COS cells. The primarystructure of MARCO already suggested that it is not a secreted protein, as it does not contain a typical signal peptide sequence. The hydrophobic sequence of domain II further indicated that MARCO is a membrane protein, and this was confirmed in various immunological studies that clearly localized the protein to the plasma membrane.
MARCO Resembles Scavenger Receptor Type I
The primary structure of the MARCO subunit chain is similar to that of the scavenger receptor, and furthermore, the predicted tertiary structure (Figure 6 ) and the polarity of amino acids next to the hydrophobic domain II strongly indicate that MARCO is an integral trimeric membrane molecule, each chain having a single membrane-spanning domain as in the scavenger receptor . The present study verified the orientation of MARCO, showing that domain V is extracellular and domain I intracellular. The 75 residue extracellular domain III of MARCO probably acts as a spacer between the plasma membrane and domain IV. The latter differs substantially from the coiled-coil region formed by domains IV and V of the scavenger receptor in that it forms a triple-helical collagenous domain interrupted at a single site by an AlaGlu-Lys sequence, while the scavenger receptor has first a long noncollagenous a-helical coiled coil followed only by a short 24 Gly-Xaa-Yaa repeat containing domain V ). The C-terminal end domains V and VI of MARCO and scavenger receptor type I, respectively, show a 48.9% similarity (Figure 7) , each containing six cysteine residues with similar spacing. This scavenger receptor cysteine-rich motif (SRCR domain) has been found in a number of other proteins. All of the known mammalian The two domain sequences have been aligned Murine SR
402 KRAHFGQGTGPIWLNE~AV~FGRESSIEh~INQWGVLS~]SHSEDAGVT~S 453 for maximal match. Solid bars between the sequences indicate conserved amino acids, and double colons depict conservative substitutions. The six conserved cysteine residues are boxed. The residues of MARCO are numbered according to Figure 1 , and those of scavenger receptor according to Freeman et al. (1990) .
SRCR domain-containing proteins are expressed on the surfaces of cells associated with the immune system and host defense functions (T cells, B cells, and macrophages) or are secreted and known or suspected of being involved in host defense (Resnick et al., 1994; Freeman et al., 1990) .
Cell Specificity and Bacteria Binding Properties of MARCO Indicate a Role in Host Defense
The binding of MARCO to bacteria and the expression of this protein in specific macrophage subpopulations indicate that it plays a role in immunological reactions, and they emphasize the heterogeneity within macrophage populations and the compartmentalization of the lymphoid system. The marginal zone macrophages of the spleen where MARCO is highly expressed form a very special population in many respects. These large macrophages are strategically positioned in the anatomical compartment of the spleen where the bloodstream leaves the small arterioles and passes into the so-called open venous system (Kraal, 1992) . Here, the phagocytosing system first contacts blood-borne pathogens, and the highly phagocytic marginal zone macrophages, especially, can bind and take up material. The antibody inhibition studies indicated that domain V contains the ligand-binding site, but since the antigen contained a small part of domain IV, it cannot be excluded that domain IV has ligand binding properties. Also, steric hindrance of the antibodies cannot be excluded.
Despite structural similarities with the scavenger receptor type I, MARCO probably has different functions, as it is present in different types of macrophages. For example, MARCO was not found in liver or lung tissues. However, MARCO binds acetylated LDL and bacteria, as do scavenger receptors, but it differs by not binding yeast. The restricted expression of MARCO in macrophages capable of binding and possibly taking up acetylated LDL points to a significant role in the clearance of serum components.
Taken together, the binding properties and restricted expression of MARCO in subpopulations of macrophages that are involved in the uptake of bacterial antigenic polysaccharides indicate that MARCO plays an important role in the host defense system and homeostasis of the body.
Experimental Procedures
Isolation and Characterization of cDNA Clones
A mouse macrophage cDNA library in ~.gt11 (CIontech ML1005) was screened with a human type Xill collagen cDNA (E-26) probe (Pihlajaniemi and Tamminen, 1990) . The clones were isolated, subcloned into pUC18/19 or M1318/19 vectors, and sequenced in accordance with standard procedures.
RNA Analysis and In Situ Hybridization
Poly(A) RNA was isolated from tissues (liver, kidney, spleen, lung, heart, muscle, brain, and thymus) of 2-month-old mice and transferred to nitrocellulose by standard methods.
In situ hybridization was carried out (Wilkinson and Green, 1990 ) on whole 14-and 17-day-old mouse embryos and on lung, liver, spleen, lymph node, kidney, and heart tissues of 9-day-old pups, as well as on bone marrow, intestine, lung, liver, spleen, lymph node, kidney, and thymus tissues of adult mice. For the preparation of RNA probes, DNA fragments (nucleotides 65-398 and 1310-1672) were amplified by polymerase chain reaction (PCR) using the Marco cDNA clone as template. PCR primers contained restriction sites for subcloning into pSP64 and pSP65 plasmid vectors (Promega).
Preparation of Antibodies
Monoclonal antibodies, ER-TR9 and MOMA-1, against macrophage antigens have previously been described (Dijkstra et al., 1985; Kraal and Janse, 1986) . For the production of polyclonal antibodies, domains of the MARCO polypeptide were expressed as glutathione S-transferase (GST) fusion proteins in the pGEX-IZT vector (Pharmacia) in E. coll. DNA fragments encoding domain I (residues 1-50) or the end of domain IV plus domain V (residues 369-518) were generated by PCR. All sequences were confirmed by DNA sequencing. Fusion proteins produced in bacteria were purified using glutathione-Sepharose 4B (Pharmacia). Antisera were raised in rabbits by using standard procedure, and IgG was first purified by protein A-Sepharose (Pharmacia) and then by negative immunoabsorption from unspecific antibodies against GST and E. coli proteins.
Immunolocalization
For staining with monoclonal antibody against the macrophage marker ER-TR9 (Kraal, 1992) , cryosections were incubated first with the antibody and then with horseradish peroxidase (HRP)-conjugated rabbit anti-rat IgG second antibody (Dako, Denmark). HRP activity was demonstrated with aminoethyl carbazole (AEC) and H202, resulting in a red reaction product. For double staining, the sections were thereafter incubated with rabbit anti-MARCO IgG (100 pg/ml) against domain I or domain V and incubated with a swine anti-rabbit IgG-H RP conjugate (Dako, Denmark). HRP activity was now demonstrated using 4-chloro-1-naphtol and H202, resulting in a blue reaction product. For immunofluorescence microscopy, sections were incubated with anti-MARCO IgG (100 i~g/ml) and then with FITC-conjugated goat anti-rabbit IgG (Cappel).
For field emission electron microscopy, cells were fixed with 4% and 8% paraformaldehyde for 10 rain each, followed by incubation with anti-MARCO IgG anti-rabbit IgG labeled with 30 nm gold particles (Amersham). The cells were postfixed with 2.5% glutaraldehyde, dehydrated in alcohol, dried in Balzers CPD 030 critical point dryer, coated with a thin carbon layer, and examined in a Jeol JSM-6300 F electron microscope.
Immunoprecipitation and SDS-PAGE
Immunoprecipitation was carried out according to standard procedures (Sambrook et al., 1989) . Prior to immunoprecipitation, the membranes were partially purified from mouse spleen and kidney according to the protocols of Schneider et al. (1980) , and the membranes and cells were extracted into a triple detergent buffer (50 mM Tris-HCI [pH 8], 150 mM NaCI, 1% Nonidet P-40, 0.1% SDS, 0.5% sodiumdeoxycholate, 100 p~g/ml phenylmethylsulfonyl fluoride (PMSF), 0.02% sodium azide, 1 ~tg/ml aprotinin). The immunoprecipitation was then carried out essentially as described elsewhere (Sam brook et al., 1989) .
Reduced and nonreduced samples were separated by SDS-PAGE. Gels with radioactive protein samples were impregnated in EN ~ HANCE (Du Pont) prior to film exposure. Western blot analysis was carried out according to the protocols of Sambrook et al. (1989) , using MARCO antisera dilutions of 1:50 to 1:100. The membranes were incubated with alkaline phosphatase-conjugated anti-rabbit IgG (Sigma) and developed with nitroblue tetrazolium-5-bromo-4-chloro-3-indolyl phosphate.
Cell Culture, Transfections, and Metabolic Labeling Cell lines IC-21 and COS7 were from the American Type Culture Collection. IC-21 transformed mouse macrophages were grown in RPMI 1640 medium, and COS7 cells in high glucose (4.5 g/I) Dulbecco's modified Eagle's medium (DMEM) (GIBCO) were supplemented with 10% fetal calf serum (FCS), 2 mM L-glutamine, 100 IU/ml penicillin, and 75 i~g/ml ascorbate. For cell transfections, a cDNA fragment containing the entire coding region of MARCO with the authentic translation initiation sequence was generated by oligonucleotide-primed PCR. The product was cloned into the pSG5 expression vector (Stratagene; Green et al., 1988 ) through use of Bglll restriction sites engineered into the primers. Additionally, a construct made with a 5' PCR primer containing an additional consensus sequence, GCCGCCAC-CATGG (Kozak, 1989) , was made for more effective initiation of translation. A construct containing the coding region in the opposite orientation (3'-5') was used as a control. A day before transfection, COS7 cells were plated at 7 x 1~ cells per 90 mm tissue culture dish and then transfected overnight by the calcium phosphate method using 20 ~g of DNA isolated with CsCI gradient centrifugation. After 18 hr, the calcium phosphate precipitate was removed, and the cells were used for immunostaining or binding assays.
For metabolic labeling, cells were incubated for 1 hr or 4 hr in methione-free DMEM containing 200 i~Ci/ml pS]methionine (Amersham; >1000 Ci/mmol) and 10% dialyzed FCS. The cells were then chased for 0, 3, 8, or 18 hr in medium suplementec' with unlabeled methionine. In N-glycosylation inhibition studies, 3 t~g/ml tunicamycin was included in the medium 3 hr before labeling and during the 4 hr labeling period.
Ligand Binding Studies IC-21 macrophages (positive control) ana transfected COS cells cultured on coverslips were incubated with fluorescence-labeled ligand candidates (Molecular Probes, Incorporated); with FITC-labeled E. coil, S. aureus, or Zymosan A (S. cerevisiae) for 1 hr; with FITC-labeled Ficoll (50-100 p.g/ml) or with Dil-labeled Ac-LDL (5 i~g/ml) for 3-5 hr. Bacteria and cells were incubated in ratios of 50:1 to 100:1. In the Zymosan A binding studies, higher particle amounts and longer incubation times were also tested. Following incubation, the cells were immunostained with anti-MARCO IgG and FITC-or rhodamine-labeled secondary antibodies. As negative controls, COS cells transfected with a plasmid containing cDNA in the wrong orientation were used. Binding inhibition studies were carried out by adding normal rabbit IgG and MARCO anti-rabbit IgG (25-500 p.g/ml) or preimmune and anti-MARCO sera at dilutions of 1:10 to 1:100 prior to the addition of ligands. Bound bacteria were counted from 100 cells positive with anti-MARCO antibodies, each experiment being carried out in triplicate.
